Hancock Whitney Corp Meridian Bioscience Inc Transaction History

Hancock Whitney Corp

$2.92 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Nov 13, 2023	BUY	$31.15 - $33.39 $489,397 - $524,590	15,711 New	15,711 $521,000
Q4 2022 Feb 03, 2023	SELL	$31.15 - $33.39 $4,329 - $4,641	-139 Reduced 0.88%	15,711 $521,000
Q3 2022 Oct 26, 2022	SELL	$30.9 - $33.55 $18,725 - $20,331	-606 Reduced 3.68%	15,850 $500,000
Q2 2022 Aug 08, 2022	BUY	$23.75 - $31.69 $285 - $380	12 Added 0.07%	16,456 $500,000
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $2,855 - $3,852	143 Added 0.88%	16,444 $427,000
Q4 2021 Jan 25, 2022	SELL	$17.46 - $21.61 $18,961 - $23,468	-1,086 Reduced 6.25%	16,301 $334,000
Q3 2021 Nov 04, 2021	SELL	$17.35 - $22.5 $517,897 - $671,625	-29,850 Reduced 63.19%	17,387 $334,000
Q2 2021 Aug 09, 2021	BUY	$18.01 - $28.32 $6,969 - $10,959	387 Added 0.83%	47,237 $1.05 Million
Q1 2021 May 14, 2021	BUY	$19.76 - $29.89 $451,180 - $682,478	22,833 Added 95.07%	46,850 $1.23 Million
Q4 2020 Feb 09, 2021	BUY	$15.73 - $21.66 $10,161 - $13,992	646 Added 2.76%	24,017 $449,000
Q3 2020 Nov 05, 2020	BUY	$13.54 - $26.41 $316,443 - $617,228	23,371 New	23,371 $397,000
Q1 2019 May 13, 2019	SELL	$15.51 - $17.61 $1.28 Million - $1.46 Million	-82,653 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$14.52 - $19.72 $108,958 - $147,978	-7,504 Reduced 8.32%	82,653 $1.44 Million
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $58,449 - $64,353	-3,936 Reduced 4.18%	90,157 $1.34 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $87,837 - $106,932	6,365 Added 7.26%	94,093 $1.5 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $555,394 - $651,985	40,246 Added 84.76%	87,728 $1.25 Million
Q4 2017 Feb 12, 2018	SELL	$13.55 - $15.8 $391,798 - $456,857	-28,915 Reduced 37.85%	47,482 $665,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $149,873 - $159,902	11,143 Added 17.08%	76,397 $1.09 Million
Q2 2017 Aug 11, 2017	BUY	N/A	65,254	65,254 $1.03 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account